These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29348651)

  • 41. Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.
    Verheyden SL; Maidment R; Curran HV
    J Psychopharmacol; 2003 Dec; 17(4):371-8. PubMed ID: 14870948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study.
    Wright NE; Strong JA; Gilbart ER; Shollenbarger SG; Lisdahl KM
    PLoS One; 2015; 10(7):e0134708. PubMed ID: 26231032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
    Frokjaer VG; Erritzoe D; Holst KK; Madsen KS; Fisher PM; Madsen J; Svarer C; Knudsen GM
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.
    Bedi G; Hyman D; de Wit H
    Biol Psychiatry; 2010 Dec; 68(12):1134-40. PubMed ID: 20947066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
    Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS
    Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between ecstasy use and depression: a study controlling for poly-drug use.
    Roiser JP; Sahakian BJ
    Psychopharmacology (Berl); 2004 May; 173(3-4):411-7. PubMed ID: 14652710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
    Falck RS; Wang J; Carlson RG
    J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Socio-economic status covaries with central nervous system serotonergic responsivity as a function of allelic variation in the serotonin transporter gene-linked polymorphic region.
    Manuck SB; Flory JD; Ferrell RE; Muldoon MF
    Psychoneuroendocrinology; 2004 Jun; 29(5):651-68. PubMed ID: 15041087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
    Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression.
    Zalsman G; Huang YY; Oquendo MA; Burke AK; Hu XZ; Brent DA; Ellis SP; Goldman D; Mann JJ
    Am J Psychiatry; 2006 Sep; 163(9):1588-93. PubMed ID: 16946185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.
    Kranzler HR; Armeli S; Tennen H; Covault J
    Addict Biol; 2013 Nov; 18(6):1024-31. PubMed ID: 23145795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MDMA-induced indifference to negative sounds is mediated by the 5-HT
    Kuypers KPC; de la Torre R; Farre M; Pizarro N; Xicota L; Ramaekers JG
    Psychopharmacology (Berl); 2018 Feb; 235(2):481-490. PubMed ID: 28735368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sucrose preload reduces snacking after mild mental stress in healthy participants as a function of 5-hydroxytryptamine transporter gene promoter polymorphism.
    Markus CR; Jonkman LM; Capello A; Leinders S; Hüsch F
    Stress; 2015; 18(2):149-59. PubMed ID: 25423193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.
    Vollenweider FX; Gamma A; Liechti M; Huber T
    Neuropsychopharmacology; 1998 Oct; 19(4):241-51. PubMed ID: 9718588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.
    Kellner M; Demiralay C; Muhtz C; Husemann J; Kölsch W; Hiemke C; Yassouridis A; Wiedemann K
    Psychiatry Res; 2008 Dec; 161(3):339-43. PubMed ID: 18962988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT; Bechara A; Rizzo M; Ramaekers JG
    J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors.
    van Wel JH; Kuypers KP; Theunissen EL; Bosker WM; Bakker K; Ramaekers JG
    PLoS One; 2012; 7(7):e40187. PubMed ID: 22808116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.